Meprotabs

Meprotabs Brand names, Meprotabs Analogs

Meprotabs Brand Names Mixture

No information avaliable

Meprotabs Chemical_Formula

C₂₀H₂₃NS

Meprotabs RX_link

No information avaliable

Meprotabs fda sheet

Meprotabs msds (material safety sheet)

Meprotabs Synthesis Reference

No information avaliable

Meprotabs Molecular Weight

309.469 g/mol

Meprotabs Melting Point

< 25 ^oC

Meprotabs H₂O Solubility

Soluble as HCl salt

Meprotabs State

Liquid

Meprotabs LogP

5.7

Meprotabs Dosage Forms

Tablets (oral, 1 mg)

Meprotabs Indication

Used for the symptomatic treatment of parkinsonism.

Meprotabs Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meprotabs Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meprotabs side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meprotabs Patient Information

Meprotabs Organisms Affected

Humans and other mammals